Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Bone marrow derived elements and resident microglia in brain inflammation.
Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature.
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series.
Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis.
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status.
Cost-effectiveness of natalizumab in multiple sclerosis: an updated systematic review.
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study.
Multimodal imaging of subventricular zone neural stem/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum.
Cerebrospinal fluid analysis in the context of CNS demyelinating diseases.
PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: A comparison between [(11)C]CIC and [(11)C]MeDAS.
Regulatory dendritic cell therapy: From rodents to clinical application.
Comparison of 3D Cube FLAIR with 2D FLAIR for Multiple Sclerosis Imaging at 3 Tesla.
PML after natalizumab discontinuation: Few and true?
Attributional style and depression in multiple sclerosis: the learned helplessness model.
Impaired functional integration in multiple sclerosis: a graph theory study.
Cerebrospinal fluid proteomics in multiple sclerosis.
PML in a patient with lymphocytopenia treated with dimethyl fumarate.
Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.
SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function.
Preferential Recruitment of Neutrophils into the Cerebellum and Brainstem Contributes to the Atypical Experimental Autoimmune Encephalomyelitis Phenotype.
Cognitive-motor related brain activity during walking: differences between men and women with multiple sclerosis.
Adjusted Indirect Comparison of Oral Multiple Sclerosis Agents.
Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.
'The worm that got away': parainfectious atypical optic neuritis associated with schistosomiasis infection.
Epigenetic in Multiple Sclerosis: Molecular mechanisms and dietary intervention.
Pages
« first
‹ previous
…
544
545
546
547
548
549
550
551
552
…
next ›
last »